Roche launches Elecsys PRO-C3 test for liver fibrosis Ruchika Sharma6 May 2025 11:30 AM ISTBasel: Roche has announced the launch of its ElecsysPRO-C3 test, a new diagnostic solution designed to assess the severity of liver fibrosis in...
EMA Committee recommends EU label update for Roche Phesgo to allow administration outside of clinical settings Ruchika Sharma4 May 2025 1:30 PM ISTBasel: Roche has announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive...
Roche secures USFDA Breakthrough Device Designation for AI-driven companion diagnostic for non small cell lung cancer Ruchika Sharma29 April 2025 11:45 AM ISTBasel: Roche has announced that the VENTANA TROP2 (EPR20043) RxDx Device for non-small cell lung cancer has received Breakthrough Device...
Roche gets CE Mark for Chest Pain Triage algorithm Ruchika Sharma25 April 2025 1:30 PM ISTBasel: Roche has announced the introduction of its Chest Pain Triage algorithm as part of the navify Algorithm Suite.Developed in collaboration...
Roche to infuse USD 50 billion in pharma, diagnostics in US over next five years Ruchika Sharma22 April 2025 10:30 AM ISTBasel: Roche has announced today that it will invest USD 50 billion into the United States of America in the next five years. These investments...
Roche Columvi gets European Commission nod as bispecific antibody for diffuse large B-cell lymphoma after initial therapy Ruchika Sharma14 April 2025 12:30 PM ISTBasel: Roche has announced that the company has received approval from the European Commission for Columvi (glofitamab) in...
Risdiplam Price Disparity in India vs China, Pakistan: SC Issues Notice to Roche Farhat Nasim6 April 2025 2:00 PM ISTIt was submitted that why can't the Indian government negotiate with Roche to make the medicine for the rare disorder available at a cheaper rate.
Setback to Roche: Plea Against Natco on Risdiplam Patent Rejected by Delhi HC Farhat Nasim25 March 2025 5:31 PM ISTNew Delhi: In a major relief to Indian drugmaker Natco Pharma, the Delhi High Court has rejected an interim injunction plea filed by Swiss...
submit phase I and phase II data for Crohn's disease: CDSCO Panel tells Roche Products India on RO7790121 study Dr. Divya Colin22 March 2025 6:00 PM ISTNew Delhi: Reviewing Phase III clinical study protocol of the monoclonal antibody RO7790121, the Subject Expert Committee (SEC) functional under the...
Roche, Zealand Pharma ink pact to co-develop, co-commercialise petrelintide as foundational therapy for obesity Ruchika Sharma14 March 2025 1:30 PM ISTBasel: Roche has announced that it has entered into an exclusive collaboration and licensing agreement with Zealand Pharma. Under the terms of this...
Conduct Phase III CT in Indian population: CDSCO Panel tells Roche Products India on Baloxavir marboxil Dr. Divya Colin6 March 2025 6:00 PM ISTNew Delhi: Noting that the Indian patient’s clinical data is not sufficient and acute uncomplicated influenza is not an unmet medical need, the...
Roche Gazyva application accepted by USFDA for lupus nephritis Ruchika Sharma5 March 2025 1:45 PM ISTGazyva/Gazyvaro is an anti-CD20 monoclonal antibody in a randomised phase III study to demonstrate a CRR benefit in lupus nephritis.
